Baseline hs-CRP predicts hypertension remission in metabolic syndrome.
Federico CarboneEdorado EliaMatteo CasulaAldo BonaventuraLuca LiberaleMaria BertolottoNathan ArtomSilvia MinettiFranco DallegriPaola ContiniDaniela VerzolaRoberto PontremoliFranesca ViazziGiorgio Luciano VivianiStefano BertoliniAldo PendeLivia PisciottaFabrizio MontecuccoPublished in: European journal of clinical investigation (2019)
Remission of hypertension in MetS is independently associated with baseline low CRP levels, which might suggest a critical role for inflammation in sustaining high blood pressure levels.